Among other things, there is no guarantee that planned or ongoing studies will be completed as planned, that future study results will be consistent with expectations or study results to date, that retatrutide will prove to be a safe and effective treatment for obesity or overweight and knee osteoarthritis or other potential indications, that retatrutide will receive regulatory approval, or that Lilly will execute its strategy as expected
This remains the recommended approach for researchers who are new to semaglutide, still titrating, or uncomfortable with sterile technique
This part of Nestl Health Sciences business, which we call Active Nutrition, is growing strongly. Meeting the vitamin and gut health needs of GLP-1 patients is also an area of opportunity, claimed Schneider
They are best equipped to provide guidance specific to your medical needs
The changes make the peptide more resistant to enzymatic degradation, which enables it to be used in research studies over a long duration
GLP-1s Results vary
